Neurocrine Bioscience buy Citigroup Inc.
Start price
06.05.26
/
50%
€123.15
Target price
06.05.27
€209.89
Performance (%)
28.58%
Price
14:01
€158.35
Summary
This prediction is currently active. The prediction currently has a performance of 28.58%. This prediction currently runs until 06.05.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Neurocrine Bioscience | 2.294% | 2.294% |
| iShares Core DAX® | 1,72 % | 3,37 % |
| iShares Nasdaq 100 | -4,56 % | -4,24 % |
| iShares Nikkei 225® | -7,12 % | -11,87 % |
| iShares S&P 500 | -0,89 % | 1,69 % |
Comments by Citigroup_Inc_ for this prediction
In the thread Neurocrine Bioscience diskutieren
Neurocrine Biosciences (NBIX) had its price target raised by Citigroup Inc. from $242.00 to $246.00. They now have a "buy" rating on the stock.
Ratings data for NBIX provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Neurocrine Bioscience
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€112.90
07.04.26
07.04.26
€209.89
07.04.27
07.04.27
40.26%
14:01
14:01
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€103.35
12.02.26
12.02.26
€171.73
12.02.27
12.02.27
53.22%
14:01
14:01
Neurocrine Bioscience
Start price
Target price
Perf. (%)
€117.75
29.10.25
29.10.25
€174.28
29.10.26
29.10.26
34.48%
14:01
14:01